DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 188 filers reported holding DENALI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,087,541 | -30.1% | 52,767 | +0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,554,946 | +59.9% | 52,754 | +25.1% | 0.00% | 0.0% |
| Q1 2023 | $972,174 | +120.1% | 42,168 | +165.4% | 0.00% | – |
| Q4 2022 | $441,719 | -9.6% | 15,889 | -50.0% | 0.00% | – |
| Q3 2022 | $488,488 | +3.5% | 31,780 | +97.8% | 0.00% | – |
| Q2 2022 | $472,000 | -82.5% | 16,068 | -80.8% | 0.00% | -100.0% |
| Q1 2022 | $2,692,000 | -39.9% | 83,695 | -16.7% | 0.00% | -50.0% |
| Q4 2021 | $4,480,000 | +1028.5% | 100,463 | +1176.5% | 0.00% | – |
| Q3 2021 | $397,000 | -9.8% | 7,870 | -72.0% | 0.00% | – |
| Q4 2017 | $440,000 | – | 28,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 7,705,039 | $343,645,000 | 25.68% |
| Casdin Capital, LLC | 1,500,000 | $66,900,000 | 1.89% |
| Flagship Pioneering Inc. | 2,619,968 | $116,851,000 | 1.81% |
| SECTORAL ASSET MANAGEMENT INC | 189,600 | $8,456,000 | 1.27% |
| Integral Health Asset Management, LLC | 100,000 | $4,460,000 | 1.23% |
| Temasek Holdings (Private) Ltd | 5,369,487 | $239,479,000 | 0.86% |
| Goldstream Capital Management Ltd | 78,418 | $3,497,000 | 0.86% |
| Yiheng Capital Management, L.P. | 335,184 | $14,949,000 | 0.76% |
| GILDER GAGNON HOWE & CO LLC | 2,900,114 | $129,345,000 | 0.74% |
| Artal Group S.A. | 600,000 | $26,760,000 | 0.73% |